Background and Purpose Chronic migraine (CM) is a highly disabling condition that remains suboptimally treated. Metabolic disturbances may trigger migraine chronification, whereas impaired endogenous pain inhibition contributes to CM development. Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs), used for type 2 diabetes and obesity, show efficacy ...
Katarina Sićović +6 more
wiley +1 more source
GnRH-receptor antagonism as a targeted approach to reproductive dysfunction in polycystic ovary syndrome. [PDF]
Cotellessa L +7 more
europepmc +1 more source
Cardiometabolic Risk in First Degree Relatives of Women With Polycystic Ovary Syndrome (PCOS)
ABSTRACT Objective Polycystic ovary syndrome (PCOS) is a common multisystem disorder with reproductive, cardiometabolic and psychological implications. Genetic factors play a role in the pathogenesis of PCOS. We sought to investigate the cardiometabolic health of first degree relatives (FDR) of women with PCOS.
Su Jen Chua +8 more
wiley +1 more source
Shared decision-making in prostate cancer treatment: selecting an androgen deprivation therapy option. [PDF]
Collins SP, Maculaitis MC, Chakoian M.
europepmc +1 more source
Current Approaches to Support Patients to Withdraw From Image and Performance Enhancing Drugs
ABSTRACT Image and performance‐enhancing drugs (IPEDs) include agents such as androgens, growth hormone, and erythropoietin, which are used to enhance appearance and physical performance. Androgens, also known as anabolic‐androgenic steroids (AAS), are the most used IPEDs worldwide.
Elizabeth Hyams +3 more
wiley +1 more source
Molecular regulation of estrogen receptors and recent advances on ERα36 splice variant in prostate cancer. [PDF]
Souza DS +5 more
europepmc +1 more source
ABSTRACT Objective Cardiovascular disease (CVD) risk is elevated in transgender individuals during gender‐affirming hormone therapy (GAHT) with expected different mechanisms between T‐ and E2‐based GAHT. We investigated prospective changes in cardiometabolic proteins relating to complement, inflammation, and transport during GAHT.
Emilie Bukh Madsen +12 more
wiley +1 more source
Androgen-Modulating Drugs and Severe Complications After ST-Elevation Myocardial Infarction.
Colldén H +5 more
europepmc +1 more source
Androgen Receptor T878A and L702H Alterations Define Subsets of Prostate Cancer Patients with Distinct Outcomes to Androgen Receptor Pathway Inhibitors. [PDF]
Siskin M +5 more
europepmc +1 more source
ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs), dual glucose‐dependent insulinotropic polypeptide (GIP)/GLP‐1RA and triple (GIP)/GLP‐1RA/glucagon agonists achieve placebo‐subtracted weight loss of 15% to 22%. Their long‐term value depends on how well the weight loss is maintained and on the composition of weight loss, not only
Michael Zitzmann +3 more
wiley +1 more source

